FDA to pull common but ineffective cold medicine from market
The FDA announced plans to remove a common ingredient in cough and cold medicines, oral phenylephrine, from the market due to its ineffectiveness as a nasal decongestant. This decision follows concerns raised by the agency’s advisers about the initial data supporting the ingredient’s approval. Many over-the-counter medications, including Advil, NyQuil, and Sudafed, contain phenylephrine. The…